Anthropic has received multiple offers to invest at valuations as high as $800 billion in recent weeks, which would more than ...

The crypto funding landscape entered a new paradoxical phase, with the number of venture capital firms leading ...

For decades, venture capitalists have relied on a tried-and-true recipe to make money in biotech. Now that approach is being ...

You might think that some traction would make getting funded easier than no traction. You’d be wrong. I have spent the better ...

Distribution moat startup VC 2026: how AI collapsing software costs has made audience-building and go-to-market strategy the ...

Forbes contributors publish independent expert analyses and insights. Author, professor and founder. Deeply curious about leadership. Few things in life are as consistently humbling as being a VC.

VCs are frothing at the mouth to write more checks to Anthropic at a valuation that matches or beats OpenAI's.

Why is old exon science getting new traction? What’s unsettling biotech VCs? And who will be the next CEO of PhRMA?

When HawkEye 360, a satellite surveillance company that’s growing quickly, goes public, it will be just a fraction of what’s expected from SpaceX‘s behemoth listing. But the market’s reception of the ...

Berber Jin is a startups/venture capital fellow for Business Insider. He previously wrote about wealth and personal finance ...